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p53 Regulates Oxidative Stress-Mediated Retrograde
Signaling: A Novel Mechanism for ChemotherapyInduced Cardiac Injury
Joyce M. Velez1., Sumitra Miriyala1., Ramaneeya Nithipongvanitch4, Teresa Noel1,
Chotiros D. Plabplueng4, Terry Oberley2,3, Paiboon Jungsuwadee1, Holly Van Remmen5, Mary Vore1,
Daret K. St. Clair1*
1 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky, United States of America, 2 Department of Pathology and Laboratory Medicine, University
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Hospital, Madison, Wisconsin, United States of America, 4 The Faculty of Medical Technology, Mahidol University, Bangkok, Thailand, 5 Department of Cellular and
Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America

Abstract
The side effects of cancer therapy on normal tissues limit the success of therapy. Generation of reactive oxygen species
(ROS) has been implicated for numerous chemotherapeutic agents including doxorubicin (DOX), a potent cancer
chemotherapeutic drug. The production of ROS by DOX has been linked to DNA damage, nuclear translocation of p53, and
mitochondrial injury; however, the causal relationship and molecular mechanisms underlying these events are unknown.
The present study used wild-type (WT) and p53 homozygous knock-out (p532/2) mice to investigate the role of p53 in the
crosstalk between mitochondria and nucleus. Injecting mice with DOX (20 mg/kg) causes oxidative stress in cardiac tissue
as demonstrated by immunogold analysis of the levels of 4-hydroxy-29-nonenal (4HNE)-adducted protein, a lipid
peroxidation product bound to proteins. 4HNE levels increased in both nuclei and mitochondria of WT DOX-treated mice
but only in nuclei of DOX-treated p53(2/2) mice, implicating a critical role for p53 in causing DOX-induced oxidative stress in
mitochondria. The stress-activated protein c-Jun amino-terminal kinase (JNKs) was activated in response to increased 4HNE
in WT mice but not p53(2/2) mice receiving DOX treatment, as determined by co-immunoprecipitation of HNE and pJNK.
The activation of JNK in DOX treated WT mice was accompanied by Bcl-2 dissociation from Beclin in mitochondria and
induction of type II cell death (autophagic cell death), as evidenced by an increase in LC3-I/LC-3-II ratio and c-H2AX, a
biomarker for DNA damage. The absence of p53 significantly reduces mitochondrial injury, assessed by quantitative
morphology, and decline in cardiac function, assessed by left ventricular ejection fraction and fraction shortening. These
results demonstrate that p53 plays a critical role in DOX-induced cardiac toxicity, in part, by the induction of oxidative stress
mediated retrograde signaling.
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proteins in the outer membrane as well as in the matrix of the
mitochondria, including bcl-2-associated X protein (Bax), Bcl2,
p53 up-regulated modulator of apoptosis (PUMA) [1], polymerase
gamma [2], and manganese superoxide dismutase (MnSOD) [3]
It is well documented that free radical-mediated oxidative stress
plays a pivotal role in the cardiac toxicity of Doxorubicin (DOX)
[4]. We have shown that overexpression of human MnSOD, a
primary antioxidant enzyme located in the mitochondrial matrix,
protects against DOX-induced cardiac injury, suggesting that the
DOX-induced cardiac injury is related to the effect of DOX on
cardiac mitochondria [4]. However, the pathways that mediate the
observed protective effect of MnSOD remain unknown.
ROS are highly reactive and, when generated close to cell
membranes, oxidize membrane phospholipids (lipid peroxidation),
which can lead to the generation and accumulation of lipid

Introduction
Research on mitochondria has evolved from emphasizing
bioenergetics to studying biogenesis, the genetic functions of
mitochondrial DNA (mtDNA), and diseases associated with
mitochondrial dysfunction. Although these areas continue to be
investigated vigorously, a new era in mitochondrial research has
emerged that concerns the role of this organelle in intracellular
signaling.
p53, an important tumor suppressor gene, is recognized as the
guardian of the genome because it regulates the transcription of
numerous genes that code for life and death processes. However,
during the last decade, the transcription-independent activity of
the p53 protein has emerged as an important mechanism by which
p53 modulates mitochondrial function. p53 interacts with various
PLoS ONE | www.plosone.org
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To directly address this issue, we examined the levels of 4HNEprotein adducts in cardiomyocytes of WT and p53(2/2) mice using
quantitative ultrastructural immunogold analysis techniques. As
illustrated in Figure 1A, gold labeling of 4HNE-protein adducts
was infrequently found in cardiomyocyte mitochondria and
cytoplasm of saline treated WT and p53(2/2) mice (Figure 1A,
subpanel a and b). An increase in 4HNE-modified proteins
labeling was observed in mitochondria of cardiomyocytes from
DOX-treated WT but not p53(2/2) mice (Figure 1A, subpanel c
and d). Quantification of 4HNE immunoreactive protein adducts
in cardiomyocytes of DOX treated WT mice demonstrated a
significant increase in mitochondria (Figure 1C), cytoplasm
(Figure 1B) and nuclei (Figure 1D) in comparison with saline
controls. A significant increase was also observed in the nuclei
(Figure 1D) but not in cytoplasm (Figure 1C) or mitochondria
(Figure 1D) of DOX-treated p53(2/2) mice in comparison with
saline treated controls. Interestingly, cardiomyocytes from salinetreated p53(2/2) mice exhibited higher levels of 4HNE-protein
adducts in the mitochondria in comparison with saline-treated
WT mice (Figure 1C) while levels in cytoplasm (Figure 1B) and
mitochondria (Figure 1C) from DOX-treated p53(2/2) mice were
significantly lower than those in WT mice similarly treated. These
results confirm our previous observations regarding the effect of
DOX on mitochondrial 4HNE levels [18]. The results demonstrate that p53 plays a major role in increasing mitochondrial
4HNE after DOX treatment.

peroxidation products, such as malondialdehyde, 4-hydroxy-2nonenal (4HNE), acrolein and F2-isoprostanes. 4HNE is a highly
reactive and specific diffusible end-product of lipid peroxidation
and is known to induce/regulate various cellular events such as
proliferation and growth inhibition [5], T cell apoptosis [6] and
activation of signaling pathways [7]. Proteins are major targets of
4HNE, which can trigger multiple modifications of the protein
structure. 4HNE has a high affinity towards cysteine, histidine and
lysine residues forming direct protein-adducts and thereby altering
protein function.
Autophagy (Greek: ‘to eat oneself’) is an intracellular event in
which a cell digests its own constituents. The term ‘‘autophagic cell
death’’ describes a form of programmed cell death morphologically distinct from apoptosis and presumed to result from excessive
levels of cellular autophagy [8]. In classical apoptosis, or type I
programmed cell death, there is early collapse of cytoskeletal
elements but preservation of organelles until late in the process. In
contrast, in autophagic, or type II, programmed cell death there is
early degradation of organelles but preservation of cytoskeletal
elements until late stages.
Recent studies have demonstrated interactions between the
autophagic and apoptotic pathways. The Bcl-2 family has been
implicated in the crosstalk between apoptosis and autophagy [9].
Other apoptosis-related proteins such as p53 have also been shown
to play a role in autophagy [10]. Beclin1, a mammalian autophagy
gene, was originally identified as a bcl-2-interacting protein [11].
Members of the beclin1 and Bcl-2 family serve as a point of crosstalk
between the autophagic and apoptotic pathways. Beclin1 directly
interacts not only with bcl-2 but also with other anti-apoptotic
proteins of the bcl-2 family such as bcl-xL [9]. Cardiac bcl-2
overexpression also inhibits autophagy in murine heart cells [12].
This present study focuses on an understanding of the molecular
mechanisms underlying DOX-induced cardiac toxicity. It identifies p53 as a candidate in augmenting retrograde signaling leading
to cardiac injury by using genetic manipulations, functional tests,
ultrastructural analyses, and biochemical assays.

4HNE induces JNK activation and Bcl-2 phosphorylation,
and triggers autophagic cell death
JNKs are involved in activation of caspases [19,20], but their
role is not uncomplicated. JNK activation could be either
upstream [20] or downstream [19] of cell death activation,
depending on cell type and death-initiating agents. We therefore
evaluated whether DOX treatment increases JNK in mitochondria as a result of 4-HNE increase, using a phospho-specific
antibody that recognizes dual site phosphorylation of JNK at
Thr183 and Tyr185 (Figure 2A). While the total levels of JNK
were equivalent in both genotypes under identical treatment
conditions, little phosphorylated JNK was detected in p53(2/2)
mice treated with DOX. In contrast, a high level of phosphorylated JNK was detected in WT mice treated with DOX. The WT
but not p53(2/2) mice treated with DOX exhibited increased
levels of Bcl-2 phosphorylation (Figure 2B) and its associated
protein beclin1 (Figure 2C). Beclin1-Bcl-2 co-immunoprecipitation
results suggest that the increased phosphorylation of Bcl-2 inhibits
interaction with Beclin1, which is most evident in WT mice
treated with DOX (Figure 2D).
Activation of the JNK pathway has been associated with
induction of type II death (autophagic cell death). To verify the
role of p53 in DOX-induced autophagic cell death at a
biochemical level, the conversion of LC3-I to LC3-II, an indicator
of autophagy activation, was assessed by immunoblot analysis
using LC3 antibody (Figure 3A). LC3-II cleavage product was
significantly increased (p,0.001) in DOX-treated WT compared
to the p53(2/2) mice similarly treated. The role of p53 in type II
death was assessed also by c-H2AX as a biomarker for DNA
damage (Figure 3B),in DOX-treated WT, but not in p53(2/2)
mice.

Results
Absence of p53 selectively reduces DOX-induced
oxidative damage in the mitochondria
ROS are so reactive that they exist in tissues for only short
periods of time, which makes measuring them difficult. One
approach to solving this problem is to rely on biochemical assays of
oxidatively damaged products. A major problem with these assays,
however, is that the oxidatively damaged products are susceptible
to further in vitro oxidation, which hinders accurate measurement
of levels of oxidatively damaged products in cellular organelles and
in specific cell types from complex tissues. To circumvent this
problem, the Oberley [13] laboratory and others have developed
techniques to localize and quantify oxidatively damaged products
using specific antibodies coupled with electron microscopy
procedures. Two previous studies have validated the immunomorphologic approaches presented herein by documenting good
agreement between biochemical and immunomorphologic analyses in an experimental model of oxidative stress (iron nitrilotriacetate-induced injury of rat kidney [14] and analysis of oxidative
damage in skeletal muscle of aging rhesus monkey [15]).
We have previously shown that DOX causes significant oxidative
damage manifested by increased levels of 4HNE adducted protein
levels in mitochondria [16,17]. Recent studies suggest that p53 plays
an important role in maintaining mitochondrial function, but it is
not known whether the oxidative stress status of the nucleus and
mitochondria are differentially affected by p53.
PLoS ONE | www.plosone.org

p53 contributes to DOX-induced cardiac injury
To verify that the observed changes in biochemical markers are
accompanied by cardiac injury, we examined the ultrastructural
morphology of cardiac tissues, including mitochondrial injury
associated with lysosomal degradation of mitochondria, loss of
2
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Figure 1. Absence of p53 selectively reduces DOX-induced oxidative damage in the mitochondria. A. Representative immunogold
electron micrographs using antibody against 4HNE protein adducts in cardiomyocytes. Electron dense beads indicate positive staining for 4HNE
protein adducts (arrow). Left ventricular tissues from WT (a) and p53(2/2) (b) mice treated with saline demonstrate low labeling of 4HNE in
mitochondria (M) and myofilaments (Myo) (a and b). Significant increase in labeling of 4HNE protein adducts was observed in both mitochondria and
myofilaments of the WT mice hearts (c) but not in the p53(2/2) mice (d) treated with DOX. Scale bar, 1 mm. B, C, and D. 4HNE-immunoreactive protein
adducts were quantified in cardiomyocyte cytoplasm (B), mitochondria (C) and nuclei (D) for both WT and p53(2/2) mice treated with saline and DOX.
Labeling density is expressed in gold beads/mm2. All graphs represent the Mean 6 SEM for each group. *p,0.05 when compared with saline treated
mice of the same genotype, # p,0.05 when compared with WT mice similarly treated.
doi:10.1371/journal.pone.0018005.g001

best known function of p53 is its action as a transcription factor.
p53 can activate or suppress expression of its target genes in a
number of ways. The typical targets of p53, such as GADD45,
p21, PUMA, BAX, and SCO2, are involved in DNA repair, cell
cycle progression, metabolism and apoptosis. Under physiological
conditions, cellular p53 is kept at a low level by an autoregulatory
loop with MDM2, a p53 target that mediates p53 ubiquitination
and subsequent degradation by the 26S proteosome [24]. Upon
exposure to various forms of stress, such as DNA damage,
oncogenic activation, hypoxia, mitotic apparatus dysfunction,
telomere erosion, energy stress or oxidative stress, p53 coordinates
cellular responses through both transcription-dependent and
-independent mechanisms. These responses prevent or repair
genomic damage, or eliminate cells when damage is beyond
repair.
The present study identifies a novel mechanism by which p53
activation selectively enhances DOX-induced oxidative stress in
mitochondria, which is manifested by an increase in the level of
4HNE-adducted proteins in the mitochondria. Under physiological conditions, 4-HNE may act as a signaling molecule to
maintain normal cellular functions [25]. Because of the reactivity
of this and other aliphatic and aromatic aldehydes, cells have
developed mechanisms to detoxify these molecules [25]. Accumulation of 4HNE, which can induce cellular injury, may be caused
by deficiencies in the process of toxic product elimination.
Oxidative stress increases HNE-adducted proteins. This increase
is partially reduced by the conjugation of HNE with GSH that
forms the glutathione conjugate of HNE (GS-HNE) [26], which is

cristae, degeneration of mitochondria, peri-mitochondrial swelling
and disruption of mitochondrial membranes (Figure 4A). Quantification of subcellular injury demonstrated a significant increase
of cardiomyocyte mitochondria injury in both WT and p53(2/2)
mice hearts following DOX treatment (Figure 4B). However, the
levels of total cellular and mitochondrial damage in WT
cardiomyocytes were significantly greater than in the p53(2/2)
cardiomyocytes similarly treated (p,0.05) (Figure 4B). Thus, the
results from ultrastructural analysis suggest that p53 plays a role in
exacerbating DOX-induced mitochondrial injury in cardiac
tissues.
Echocardiography detects a decline in cardiac function in
patients who have received an infusion of DOX [21] as part of
chemotherapy. We and others have demonstrated that three to
five days after an injection of DOX, cardiac function significantly
declines in WT mice [22,23]. WT mice treated with DOX showed
a significant decrease (p,0.05) in the LV%EF (Figure 4C) and
LV%FS (Figure 4D), but the p53(2/2) mice similarly treated did
not. These results demonstrate that the lack of biochemical
changes in p53 deficient mice is accompanied by a significant
reduction of DOX-induced structural damage and cardiac
dysfunction.

Discussion
p53 is regarded as the guardian of the genome with the
capability of regulating many life and death processes, but whether
it plays a role in regulating retrograde signaling is unexplored. The
PLoS ONE | www.plosone.org
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Figure 2. DOX induces HNE adduction with pJNK and Bcl-2 phosphorylation, and triggers autophagic response. A. PhosphoJNK was
detected by immunoprecipitation using a polyclonal goat anti-HNE antibody followed by Western blot analysis with a rabbit polyclonal Thr183/
Tyr185 phosphorylation specific JNK antibody. Quantitative analysis represents the Mean 6 SEM (n = 5) in each group; *p,0.001 as compared to
other groups. B. Western blot analysis of p-Bcl2 in cardiac mitochondria from WT and p53(2/2) mice treated with saline or DOX and quantitative
analysis represents the Mean 6 SEM n = 5 in each group; *p,0.001 as compared to other groups. C. Western blot analysis of Beclin1 in cardiac
mitochondria from WT and p53(2/2) mice treated with saline or DOX and quantitative analysis represents the Mean 6 SEM n = 5 in each group;
*p,0.001 as compared to other groups. D. Co-immunoprecipitation of Beclin1 with Bcl-2 in cardiac mitochondria from WT and p53(2/2) mice treated
with saline or DOX and quantitative analysis represents the Mean 6 SEM n = 5 in each group; *p,0.01 as compared to other groups.
doi:10.1371/journal.pone.0018005.g002

a substrate of the multidrug resistant associated protein, MRP1
[27]. Perfusion of the rat heart with HNE leads to the formation
and efflux of GS-HNE [28], suggesting a role for MRP1 in the
clearance of GS-HNE from cardiac tissue. We have previously
observed that MRP1 likely mediates the saturable efflux of the

glutathione conjugate of HNE observed upon infusion of HNE to
the perfused heart [29] that protects the cardiomyocytes.
However, under conditions of oxidative stress, accumulated
4HNE modifies and regulates enzymes involved in mitochondrial
energy production [30], which results in the increased ROS

Figure 3. p53 triggers autophagy and cell death. A. Biochemical marker for cardiac injury by autophagy. Western blot analysis of autophagy
marker (LC3) expression in heart tissue homogenates from WT and p53(2/2) mice treated with saline or DOX. Quantitative analysis represents the
Mean 6 SEM n = 5 in each group; #p,0.001 as compared to other groups. B. Western blot analysis of gamma H2AX marker for cell death in heart
tissue nuclear extracts from WT and p53(2/2) mice treated with saline or DOX. Quantitative analysis represents the Mean 6 SEM n = 5 in each group.
#
p,0.001 as compared to other groups.
doi:10.1371/journal.pone.0018005.g003

PLoS ONE | www.plosone.org
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Figure 4. p53 contributes to DOX-induced cardiac injury. A. Representative electron micrographs demonstrating cardiomyocyte injury and
morphometric quantification of subcellular injury in cardiomyocytes in WT and p53(2/2) mice. WT (a) and p53(2/2) (b) mice treated with saline
demonstrated normal ultrastructure of heart muscle with cardiomyocytes showing numerous mitochondria (M), prominent myofilaments (Myo) and
lipids (Lip). WT (c) and p53(2/2) (d) mice treated with DOX demonstrated the following pathologic changes: lysosomal degradation of mitochondria
(asterisk), mitochondria with loss of cristae (arrow), peri-mitochondrial swelling (double arrow), disruption of mitochondrial membranes (arrowhead),
and mitochondrial degeneration (d); scale bar, 1 mm. B. Pathologic changes were quantified for saline and DOX treated mice in the mitochondria and
total cellular area (excluding nuclei). Quantification of damage for each specific compartment is expressed in the ratio of damaged area versus the
total area. All graphs represent the Mean 6 SEM for each group. *p,0.05 when compared with saline treated mice of the same genotype, and
#
p,0.05 when compared with WT mice treated with DOX. n = 6 or 7. C & D. Left ventricular function, assessed by percentage of ejection fraction
(LV%EF) (C) and fractional shortening (LV%FS) (D), is expressed in percentage of change from basal levels caused by saline and DOX three days after
injections for WT and p53(2/2) mice. All bar graphs represent the Mean 6 SEM for each group. #p,0.05 when compared to all three other groups.
n = 6–11.
doi:10.1371/journal.pone.0018005.g004

generation [31] and diminished protein degradation [32] that may
activate autophagic pathways.
The JNK1 signaling pathway has been shown to regulate
autophagy in both Drosophila and mammalian cells in response to
not only starvation but also ER stress and cytokine stimulation
(e.g., IL-2, TNFa) [33]. The diversity of stress stimuli capable of
triggering JNK1-mediated autophagy is consistent with the
hypothesis that autophagy regulation is intricately intertwined
with numerous other cellular stress response programs mediated
by JNK1 signaling. Despite the known link between JNK1 and
autophagy induction, the mechanism by which JNK1 activation
leads to autophagy induction remains undefined. In the present
study, we show that activation of JNK by 4HNE is rapid and
sustained suggesting that sustained activation and phosphorylation
of JNK may be needed for 4HNE-induced type II programmed
cell death. The JNK1 signaling pathway is associated with Bcl-2
phosphorylation, which leads to disruption of the Bcl-2/Beclin1
complex and activation of Bcl-2 inhibition of Beclin1-dependent
PLoS ONE | www.plosone.org

autophagy. Our finding shows that the level of phospho-Bcl-2 is
increased while the level of Bcl-2 is reduced in DOX-treated p53
wild-type mice which are consistent with the p53-mediated
increase in activated JNK1 in DOX-treated mice. This possibility
is further confirmed by the finding that in p53(2/2) mice, there is
no increase in JNK1 activation or Bcl-2 phosphorylation.
It is possible that autophagy may have a protective role in tissue
remodeling [10], However, our results suggest that autophagy
induced by DOX treatment is not protective to cardiac tissues
because the absence of autophagy in DOX-treated p53(2/2) mice
is accompanied by the reduced cardiac injury observed morphologically and functionally.
In conclusion, the present study demonstrates that treatment
with DOX causes oxidative stress in cardiac tissue as evidenced by
immunogold staining of 4HNE-adducted protein. The 4HNE
levels were increased in both nuclei and mitochondria of WT
DOX-treated mice but only in nuclei of DOX-treated p53(2/2)
mice. JNKs were activated in response to increased 4HNE in WT
5
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mice but not in p53(2/2) mice after DOX treatment. The
activation of the JNK pathway by 4HNE was accompanied by
induction of autophagic cell death as indicated by an increase in
LC3-I/LC-3-II ratio and c-H2AX in DOX treated WT mice
(Figure 5). The absence of p53 significantly reduced mitochondria
injury and DOX-induced cardiac toxicity, suggesting that p53
plays a critical role in mediating DOX-induced cardiac toxicity, in
part, by the induction of oxidative stress mediated retrograde
signaling.

anesthetized using Nembutal\sodium solution (65 mg/kg) (Abbott
Laboratories, North Chicago, IL). The heart was excised and
immediately processed for ultrastructural studies or frozen in
liquid nitrogen for molecular and biochemical studies.

Immunogold detection of 4HNE
Samples for staining were obtained from the same tissues used
for ultrastructural examination (described above). Procedures to
detect 4HNE were followed as previously described by Oberley
et al. [13] and Nithipongvanitch et al. [35].

Materials and Methods
Mitochondrial extract preparation

Animals

Heart mitochondria were isolated as described previously by
Mela and Seitz [36] and [37]. Briefly, the hearts were collected,
rinsed in ice-cold isolation buffer (0.225 M mannitol, 0.075 M
sucrose, 1 mM EGTA, pH 7.4), and cut into small pieces. The
heart tissue was washed three times with the isolation buffer to
remove any residual blood and homogenized at 500 rpm with a
chilled Teflon pestle in a glass cylinder with 10 strokes. The
homogenate was centrifuged at 480 g at 4uC for 5 min in a Sorval
SS 34 rotor. The resulting supernatant was filtered through a
double-layered cheesecloth and centrifuged at 7700 g at 4uC for
10 min. Supernatant was saved to check for leakage from
mitochondria using MnSOD, a mitochondrial matrix enzyme.
The pellet was rinsed with 0.5 mL of the isolation buffer with
gentle shaking to remove the ‘‘fluffy layer’’ (damaged mitochondria) on top of the pellet. The wall of the centrifuge tube was
cleaned with cotton swabs to remove lipids. The pellet was washed
by gentle resuspension in 3 mL isolation buffer using the smooth
surface of a glass rod and centrifuged at 7700 g at 4uC for 10 min.

Heterozygous mice (p53(2/+)) were maintained in our laboratory to produce p53(2/2) and wild-type (WT) littermates. p53(2/2)
mice are in the C57BL/6 background and were initially generated
in the laboratory of Dr.Tyler Jacks at the Center for Cancer
Research and Department of Biology, Massachusetts Institute of
Technology, Cambridge, MA. The targeted disrupted p53 genes
do not produce p53 protein, since 40% of their gene coding region
is eliminated by the induced mutation [34]. Male mice between 10
and 12 weeks old were used in all studies. All animal experimental
procedures were approved by the Institutional Animal Care and
Use Committee of the University of Kentucky.

DOXorubicin treatment and tissue collection
Mice were treated with a single dose of 20 mg/kg of
DOXorubicin-Adriamycin (DOXOrubicin HCl, from Bedford
Laboratories, Inc., Bedford, OH) (DOX) or saline via intraperitoneal injection (IP). Three days after treatment, mice were

Figure 5. p53 enhances DOX-induced cardiac injury, in part, via enhancement of oxidative stress in mitochondria. The absence of p53
selectively prevents DOX-mediated increase in oxidative stress indicators, including 4HNE-adducted proteins in mitochondria but not in the nucleus.
DOX-induced p53-dependent increased oxidative stress in mitochondria is associated with sustained activation of JNK1 and subsequent
phosphorylation of Bcl-2 and release of beclin from the Bcl-2-beclin complex resulting in detrimental effect of autophagy (cellular injury).
doi:10.1371/journal.pone.0018005.g005

PLoS ONE | www.plosone.org
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The supernatant was saved to check again for leakage from the
mitochondria. The washing was repeated once. The resulting
mitochondria were collected for further analysis. The purity of
mitochondria was examined using Lamin A (nuclear protein) and
IkB-a (cytoskeletal protein) by Western blotting. Protein content in
the lysate was determined by BCA protein assay (Pierce, Rockford,
IL).

Ultrastructural examination of cardiac tissues
Left ventricle tissues were processed for electron microscopic
analysis followed by quantification of mitochondria, cytoplasm,
and total cellular area damage using strict criteria for each
compartment injury and image analysis techniques as previously
described by Chaiswing et al. [18].

Cardiac function assessment
Immunoprecipitation and immunoblotting

Echocardiography measurements were taken at three days after
a single IP injection with 20 mg/kg DOX or saline with a highfrequency 30 MHz probe (Vevo 660, VisualSonic, Toronto,
Ontario).

Frozen hearts were homogenized with lysis buffer (10 mM Tris–
HCl pH 7.2, 1%Nonidet P-40, 158 mM NaCl, 1 mM EDTA,
50 mM NaF, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml
leupeptin, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate) and lysates centrifuged at 16,0006g for 10 min.
Immunoblotting (40 mg protein/well) was performed according to
Odyssey infrared imaging system (LI-COR, Lincoln, NE) with
antibodies against LC3, Beclin1, c-H2Ax and Bcl-2 (Cell Signaling
Technology, Danvers, MA) and actin (Santa Cruz Biotechnology,
Santa Cruz, CA) as the loading control. Secondary antibodies
were conjugated with Alexa680 (Molecular Probes, Carlsbad, CA)
or IRdye800 (Rockland Immunochemicals, Gilbertsville, PA), and
detected and quantified using the Odyssey infrared imaging system
(LI-COR, Lincoln, NE).
For immunoprecipitation, 250 mg of protein was taken and
antibodies (2.5 mg/ml) were incubated for 2 h at 4uC with protein
G-conjugated agarose beads (30 ml) and then washed five times
with lysis buffer. To immunoprecipitate endogenous HNE and
endogenous p-JNK, anti-HNE immunoprecipitates were subjected
to SDS-PAGE and phospho-JNK (pJNK; Thr183/Try185) (Santa
Cruz Biotechnology, Santa Cruz, CA) was detected by immunoblot. Similarly for Beclin1 and endogenous Bcl-2, anti-Beclin1
immunoprecipitates were subjected to SDS-PAGE, and Bcl-2 was
detected by immunoblot analysis.

Statistical analysis
For cardiac function assessments, each group was individually
analyzed using paired t-test to compare before and after
treatments for each parameter. A percentage of change was
calculated within each group for those parameters that were
significantly different in the previous statistical test. Percentage of
change from functional studies, morphometric quantitation from
pathology, immunoreactive protein detection of 4HNE adducts,
and all the enzymatic assays were analyzed using one-way
ANOVA followed by Newman Keuls post-test (GraphPad
Prism-4). A p value of less than 0.05 was considered a significant
difference.
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